Gene · 7301
Papers2,825
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
1,061 to 1,080 of 2,825
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| The Use of Cabozantinib in Advanced Hepatocellular Carcinoma in Hong Kong-A Territory-Wide Cohort Study. | Cancers (Basel) | 2021 | 33919277 | PubTator, text mining | PubMed |
| Chikungunya and Zika Viruses: Co-Circulation and the Interplay between Viral Proteins and Host Factors. | Pathogens | 2021 | 33918691 | PubTator, text mining | PubMed |
| RTK Inhibitors in Melanoma: From Bench to Bedside. | Cancers (Basel) | 2021 | 33918490 | PubTator, text mining | PubMed |
| Design and Synthesis of a Novel PLK1 Inhibitor Scaffold Using a Hybridized 3D-QSAR Model. | Int J Mol Sci | 2021 | 33917995 | PubTator, text mining | PubMed |
| Bionanocomposite Blown Films: Insights on the Rheological and Mechanical Behavior. | Polymers (Basel) | 2021 | 33916477 | PubTator, text mining | PubMed |
| Illumination of Molecular Pathways in Multiple Sclerosis Lesions and the Immune Mechanism of Matrine Treatment in EAE, a Mouse Model of MS. | Front Immunol | 2021 | 33912166 | PubTator, text mining | PubMed |
| Circulating Small Extracellular Vesicles Activate TYRO3 to Drive Cancer Metastasis and Chemoresistance. | Cancer Res | 2021 | 33910929 | PubTator, text mining | PubMed |
| HMGCR inhibition stabilizes the glycolytic enzyme PKM2 to support the growth of renal cell carcinoma. | PLoS Biol | 2021 | 33905408 | PubTator, text mining | PubMed |
| Neurotropic Viruses, Astrocytes, and COVID-19. | Front Cell Neurosci | 2021 | 33897376 | PubTator, text mining | PubMed |
| Downregulation of PDGFRß Signaling Overcomes Crizotinib Resistance in a TYRO3 and ALK Mutated Neuroendocrine-Like Tumor. | Transl Oncol | 2021 | 33887553 | PubTator, text mining | PubMed |
| Macrophages in Chronic Liver Failure: Diversity, Plasticity and Therapeutic Targeting. | Front Immunol | 2021 | 33868313 | PubTator, text mining | PubMed |
| New Roles for Vitamin D Superagonists: From COVID to Cancer. | Front Endocrinol (Lausanne) | 2021 | 33868174 | PubTator, text mining | PubMed |
| Update on the Mechanisms of Tubular Cell Injury in Diabetic Kidney Disease. | Front Med (Lausanne) | 2021 | 33859992 | PubTator, text mining | PubMed |
| TYRO3 induces anti-PD-1/PD-L1 therapy resistance by limiting innate immunity and tumoral ferroptosis. | J Clin Invest | 2021 | 33855973 | PubTator, text mining | PubMed |
| Chemotherapy confers a conserved secondary tolerance to EGFR inhibition via AXL-mediated signaling bypass. | Sci Rep | 2021 | 33850249 | PubTator, text mining | PubMed |
| Myeloid cell-derived PROS1 inhibits tumor metastasis by regulating inflammatory and immune responses via IL-10. | J Clin Invest | 2021 | 33848267 | PubTator, text mining | PubMed |
| Telomeric Double Strand Breaks in G1 Human Cells Facilitate Formation of 5' C-Rich Overhangs and Recruitment of TERRA. | Front Genet | 2021 | 33841503 | PubTator, text mining | PubMed |
| Molecular interactions of miR-338 during tumor progression and metastasis. | Cell Mol Biol Lett | 2021 | 33827418 | PubTator, text mining | PubMed |
| The Role of Cabozantinib as a Therapeutic Option for Hepatocellular Carcinoma: Current Landscape and Future Challenges. | J Hepatocell Carcinoma | 2021 | 33824862 | PubTator, text mining | PubMed |
| Comparative Efficacy of Cabozantinib and Ramucirumab After Sorafenib for Patients with Hepatocellular Carcinoma and Alpha-fetoprotein ≥ 400 ng/mL: A Matching-Adjusted Indirect Comparison. | Adv Ther | 2021 | 33822328 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/7301/papers?page=54